Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Squamous Cell × tocilizumab × 1 year × Clear all

Sponsor

Conditions

Multiple Myeloma 10 Lymphoma, Non-Hodgkin 7 Lymphoma, Large B-Cell, Diffuse 4 Carcinoma, Non-Small-Cell Lung 4 Recurrence 3 Melanoma 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Breast Neoplasms 3 Urinary Bladder Neoplasms 2 Lymphoma, Follicular 2 Lymphoma 2 Craniopharyngioma 2 Urethral Neoplasms 1 Ureteral Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Sarcoma 1 Respiratory Tract Infections 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleural Effusion, Malignant 1 Pancreatic Neoplasms 1 Pancreatic Adenocarcinoma 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplasms 1 Nasopharyngeal Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1

Interventions

pembrolizumab 23 Cisplatin 20 Carboplatin 13 Paclitaxel 10 Radiotherapy 8 Radiotherapy, Intensity-Modulated 7 Docetaxel 7 cemiplimab 6 Nivolumab 6 Fluorouracil 6 Radiation 5 durvalumab 4 Drug Therapy 4 Taxes 3 Surveys and Questionnaires 3 Cetuximab 3 Blood Specimen Collection 3 toripalimab 2 atezolizumab 2 alpha-2'-deoxythioguanosine 2 Surgical Procedures, Operative 2 Standard of Care 2 Photochemotherapy 2 Petrolatum 2 Pemetrexed 2 vistusertib 1 talazoparib 1 sitravatinib 1 regorafenib 1 palbociclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡